IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruiting · NCT06819293 · Registry updated 2026-04-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma | Adult; Advanced Clear Renal Cell Carcinoma | Recruiting | Phase 1 | 2026-04-14 | NCT06819293 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grit Biotechnology | 19 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji hospital, Huazhong University of Science and Technology | Wuhan | China | 2 |